Literature DB >> 9507810

Hepatitis C virus and hepatocellular carcinoma.

K Kiyosawa1, E Tanaka, T Sodeyama.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9507810     DOI： 10.1159/000060478

Source DB:  PubMed          Journal:  Curr Stud Hematol Blood Transfus        ISSN： 0258-0330


× No keyword cloud information.
  7 in total

1.  Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA.

Authors:  Jashmin Vyas; Androulla Elia; Michael J Clemens
Journal:  RNA       Date:  2003-07       Impact factor: 4.942

2.  Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection.

Authors:  Mika Kurokawa; Naoki Hiramatsu; Tsugiko Oze; Takayuki Yakushijin; Masanori Miyazaki; Atsushi Hosui; Takuya Miyagi; Yuichi Yoshida; Hisashi Ishida; Tomohide Tatsumi; Shinichi Kiso; Tatsuya Kanto; Akinori Kasahara; Sadaharu Iio; Yoshinori Doi; Akira Yamada; Masahide Oshita; Akira Kaneko; Kiyoshi Mochizuki; Hideki Hagiwara; Eiji Mita; Toshifumi Ito; Yoshiaki Inui; Kazuhiro Katayama; Harumasa Yoshihara; Yasuharu Imai; Eijirou Hayashi; Norio Hayashi; Tetsuo Takehara
Journal:  J Gastroenterol       Date:  2012-01-11       Impact factor: 7.527

3.  Detection of a novel unglycosylated form of hepatitis C virus E2 envelope protein that is located in the cytosol and interacts with PKR.

Authors:  Nicole Pavio; Deborah R Taylor; Michael M C Lai
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

4.  Development of hepatocellular carcinoma in patients with chronic hepatitis C more than 10 years after sustained virological response to interferon therapy.

Authors:  Keiichiro Nojiri; Kazushi Sugimoto; Katsuya Shiraki; Satoko Kusagawa; Junichiro Tanaka; Tetsuya Beppu; Norihiko Yamamoto; Yoshiyuki Takei; Akira Hashimoto; Atsuya Shimizu; Shigeru Omori; Masahiko Tameda; Koujiro Takase
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

Review 5.  Hepatitis C virus infection in the elderly: epidemiology, natural history and management.

Authors:  Francesca Cainelli
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

6.  Viral hepatitis and hepatocellular carcinoma.

Authors:  Peter P Michielsen; Sven M Francque; Jurgen L van Dongen
Journal:  World J Surg Oncol       Date:  2005-05-20       Impact factor: 2.754

7.  Replication fitness and NS5B drug sensitivity of diverse hepatitis C virus isolates characterized by using a transient replication assay.

Authors:  Steven W Ludmerer; Donald J Graham; Evelyn Boots; Edward M Murray; Amy Simcoe; Eric J Markel; Jay A Grobler; Osvaldo A Flores; David B Olsen; Daria J Hazuda; Robert L LaFemina
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.